Ken Mills

Dr Mills' interests are in translational research in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS). These studies are aimed at improving diagnosis, prognosis and prediction of therapeutic responses. In addition, there is a focus on identifying novel single or novel combination therapies for elderly patients with MDS-AML.